Year: 2002
Type: article
Study design: Observational Study
Abstract: AIMS AND METHOD Atypical antipsychotics have less neurological side-effects than the older drugs but are only available as oral preparations. This may limit their use in forensic patients. We sent a postal questionnaire to all consultant psychiatrists working in forensic settings in the UK to determine their views. RESULTS The response rate was 60%. Respondents tended to overestimate the benefits and underestimate the side-effects of the atypical antipsychotics. The majority often prescribed atypical antipsychotics and depots together. Psychoeducation and serum level monitoring were used to optimise/monitor compliance by 50%. CLINICAL IMPLICATIONS Using atypical antipsychotics as monotherapy is problematic in forensic settings. The extent of polypharmacy means that patients may experience the side-effects of both typical and atypical antipsychotics. More could be done to facilitate and monitor compliance.
Source: Psychiatric Bulletin
DOI: 10.1192/pb.26.5.172
Authors: Carol Paton, Jose A. Garcia, Deborah Brooke
Institution: Oxleas NHS Foundation Trust
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: Eli Lilly and Company, Pfizer, AstraZeneca, Cilag
OpenAlex ID: W2008441808
